The potential biomarker panels for identification of Major Depressive Disorder (MDD) patients with and without Early Life Stress (ELS) by metabonomic analysis

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Ding, Xinghua ^a   Yang, Shuguang ^a   Li, Wuju ^a   Liu, Yong ^a   Li, Zhiguo ^a   Zhang, Yan ^b   Li, Lingjiang ^b   Liu, Shaojun ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ASPARTIC ACID; BIOLOGICAL MARKER; GALACTOSE; GLUCONIC ACID; GLUCOSE; GLYCERIC ACID; GLYCINE; HYDROXYBUTYRIC ACID; INOSITOL; ISOCITRIC ACID; LACTIC ACID; LEUCINE; LINOLEIC ACID; MANNOSE; OLEIC ACID; OXALIC ACID; PALMITIC ACID; PHOSPHORIC ACID; PROLINE; PYROGLUTAMIC ACID; SERINE; SORBITOL; STEARIC ACID; SUCCINIC ACID; THREONINE; TRYPTOPHAN; UREA; VALINE;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EARLY LIFE STRESS; GAS CHROMATOGRAPHY; HUMAN; HUMAN CELL; MAJOR DEPRESSION; MASS SPECTROMETRY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; VALIDATION STUDY; AGE; BLOOD; COMPARATIVE STUDY; DEPRESSIVE DISORDER, MAJOR; DISCRIMINANT ANALYSIS; MASS FRAGMENTOGRAPHY; MENTAL STRESS; METABOLOMICS; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PRINCIPAL COMPONENT ANALYSIS; PROCEDURES;

AGE FACTORS; BIOLOGICAL MARKERS; DEPRESSIVE DISORDER, MAJOR; DISCRIMINANT ANALYSIS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; METABOLOMICS; MULTIVARIATE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; STRESS, PSYCHOLOGICAL;

EID: 84901631422     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097479     Document Type: Article

References (63)

1. Simon GE (2003) Social and economic burden of mood disorders. Biol Psychiatry 54: 208-215.
2. Kendler KS, Kessler RC, Walters EE, MacLean C, Neale MC, et al. (1995) Stressful life events, genetic liability, and onset of an episode of major depression in women. Am J Psychiatry 152: 833-842.
3. Dube SR, Anda RF, Felitti VJ, Chapman DP, Williamson DF, et al. (2001) Childhood abuse, household dysfunction, and the risk of attempted suicide throughout the life span: findings from the Adverse Childhood Experiences Study. JAMA 286: 3089-3096. (Pubitemid 34016523)
4. Heim C, Newport DJ, Mletzko T, Miller AH, Nemeroff CB (2008) The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology 33: 693-710.
5. Edwards VJ, Holden GW, Felitti VJ, Anda RF (2003) Relationship between multiple forms of childhood maltreatment and adult mental health in community respondents: results from the adverse childhood experiences study. Am J Psychiatry 160: 1453-1460. (Pubitemid 41070921)
6. Chapman DP, Whitfield CL, Felitti VJ, Dube SR, Edwards VJ, et al. (2004) Adverse childhood experiences and the risk of depressive disorders in adulthood. J Affect Disord 82: 217-225. (Pubitemid 39370823)
7. MacMillan HL, Fleming JE, Streiner DL, Lin E, Boyle MH, et al. (2001) Childhood abuse and lifetime psychopathology in a community sample. Am J Psychiatry 158: 1878-1883. (Pubitemid 33054782)
8. Ladd CO, Huot RL, Thrivikraman KV, Nemeroff CB, Meaney MJ, et al. (2000) Long-term behavioral and neuroendocrine adaptations to adverse early experience. Prog Brain Res 122: 81-103. (Pubitemid 30114471)
9. Sanchez MM, Ladd CO, Plotsky PM (2001) Early adverse experience as a developmental risk factor for later psychopathology: evidence from rodent and primate models. Dev Psychopathol 13: 419-449. (Pubitemid 33406337)
10. Meaney MJ, Szyf M (2005) Environmental programming of stress responses through DNA methylation: life at the interface between a dynamic environment and a fixed genome. Dialogues Clin Neurosci 7: 103-123. (Pubitemid 40961531)
11. Chen L, Eaton WW, Gallo JJ, Nestadt G (2000) Understanding the heterogeneity of depression through the triad of symptoms, course and risk factors: a longitudinal, population-based study. J Affect Disord 59: 1-11. (Pubitemid 30256232)
12. Wittchen HU, Hofler M, Meister W (2001) Prevalence and recognition of depressive syndromes in German primary care settings: poorly recognized and treated? Int Clin Psychopharmacol 16: 121-135. (Pubitemid 32402357)
13. Mitchell AJ, Vaze A, Rao S (2009) Clinical diagnosis of depression in primary care: a meta-analysis. Lancet 374: 609-619.
14. Laugeray A, Launay JM, Callebert J, Surget A, Belzung C, et al. (2010) Peripheral and cerebral metabolic abnormalities of the tryptophan-kynurenine pathway in a murine model of major depression. Behav Brain Res 210: 84-91.
15. Horrobin DF, Bennett CN (1999) Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes. Prostaglandins Leukot Essent Fatty Acids 60: 217-234. (Pubitemid 29306598)
16. Ashcroft GW, Crawford TB, Eccleston D, Sharman DF, MacDougall EJ, et al. (1966) 5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases. Lancet 2: 1049-1052.
17. Fernie AR, Trethewey RN, Krotzky AJ, Willmitzer L (2004) Metabolite profiling: from diagnostics to systems biology. Nat Rev Mol Cell Biol 5: 763-769. (Pubitemid 39208185)
18. Bjerrum JT, Nielsen OH, Hao F, Tang H, Nicholson JK, et al. (2010) Metabonomics in ulcerative colitis: diagnostics, biomarker identification, and insight into the pathophysiology. J Proteome Res 9: 954-962.
19. Bertram HC, Duus JO, Petersen BO, Hoppe C, Larnkjaer A, et al. (2009) Nuclear magnetic resonance-based metabonomics reveals strong sex effect on plasma metabolism in 17-year-old Scandinavians and correlation to retrospective infant plasma parameters. Metabolism 58: 1039-1045.
20. Pasikanti KK, Ho PC, Chan EC (2008) Gas chromatography/mass spectrometry in metabolic profiling of biological fluids. J Chromatogr B Analyt Technol Biomed Life Sci 871: 202-211.
21. Koh Y, Pasikanti KK, Yap CW, Chan EC (2010) Comparative evaluation of software for retention time alignment of gas chromatography/time-of-flight mass spectrometry-based metabonomic data. J Chromatogr A 1217: 8308-8316.
22. Krall L, Huege J, Catchpole G, Steinhauser D, Willmitzer L (2009) Assessment of sampling strategies for gas chromatography-mass spectrometry (GC-MS) based metabolomics of cyanobacteria. J Chromatogr B Analyt Technol Biomed Life Sci 877: 2952-2960.
23. Zhang F, Jia Z, Gao P, Kong H, Li X, et al. (2010) Metabonomics study of urine and plasma in depression and excess fatigue rats by ultra fast liquid chromatography coupled with ion trap-time of flight mass spectrometry. Mol Biosyst 6: 852-861.
24. Ni Y, Su M, Lin J, Wang X, Qiu Y, et al. (2008) Metabolic profiling reveals disorder of amino acid metabolism in four brain regions from a rat model of chronic unpredictable mild stress. FEBS Lett 582: 2627-2636.
25. Zheng S, Yu M, Lu X, Huo T, Ge L, et al. (2010) Urinary metabonomic study on biochemical changes in chronic unpredictable mild stress model of depression. Clin Chim Acta 411: 204-209.
26. Paige LA, Mitchell MW, Krishnan KR, Kaddurah-Daouk R, Steffens DC (2007) A preliminary metabolomic analysis of older adults with and without depression. Int J Geriatr Psychiatry 22: 418-423. (Pubitemid 46831684)
27. Zheng P, Gao HC, Li Q, Shao WH, Zhang ML, et al. (2012) Plasma metabonomics as a novel diagnostic approach for major depressive disorder. J Proteome Res 11: 1741-1748.
28. Wuju L, Momiao X (2002) Tclass: tumor classification system based on gene expression profile. Bioinformatics 18: 325-326. (Pubitemid 34183113)
29. Wu B, Cha L, Du Z, Ying X, Li H, et al. (2007) Construction of mathematical model for high-level expression of foreign genes in pPIC9 vector and its verification. Biochem Biophys Res Commun 354: 498-504. (Pubitemid 46161351)
30. Xiao T, Ying W, Li L, Hu Z, Ma Y, et al. (2005) An approach to studying lung cancer-related proteins in human blood. Mol Cell Proteomics 4: 1480-1486. (Pubitemid 41555474)
31. Yang J, Chen T, Sun L, Zhao Z, Qi X, et al. (2013) Potential metabolite markers of schizophrenia. Mol Psychiatry 18: 67-78.
32. First MB, Donovan S, Frances A (1996) Nosology of chronic mood disorders. Psychiatr Clin North Am 19: 29-39. (Pubitemid 26077726)
33. Zung WW (1965) A Self-Rating Depression Scale. Arch Gen Psychiatry 12: 63-70.
34. Zung WW (1971) A rating instrument for anxiety disorders. Psychosomatics 12: 371-379.
35. Zung WW (1974) The measurement of affects: depression and anxiety. Mod Probl Pharmacopsychiatry 7: 170-188.
36. Sharp LK, Lipsky MS (2002) Screening for depression across the lifespan: a review of measures for use in primary care settings. Am Fam Physician 66: 1001-1008.
37. Bremner JD, Vermetten E, Mazure CM (2000) Development and preliminary psychometric properties of an instrument for the measurement of childhood trauma: the Early Trauma Inventory. Depress Anxiety 12: 1-12.
38. Fink LA, Bernstein D, Handelsman L, Foote J, Lovejoy M (1995) Initial reliability and validity of the childhood trauma interview: a new multidimensional measure of childhood interpersonal trauma. Am J Psychiatry 152: 1329-1335.
39. Feng B, Wu S, Lv S, Liu F, Chen H, et al. (2007) Metabolic profiling analysis of a D-galactosamine/lipopolysaccharide-induced mouse model of fulminant hepatic failure. J Proteome Res 6: 2161-2167. (Pubitemid 46985102)
40. Arvelo MB, Cooper JT, Longo C, Daniel S, Grey ST, et al. (2002) A20 protects mice from D-galactosamine/lipopolysaccharide acute toxic lethal hepatitis. Hepatology 35: 535-543. (Pubitemid 34183956)
41. Fiehn O, Kopka J, Dormann P, Altmann T, Trethewey RN, et al. (2000) Metabolite profiling for plant functional genomics. Nat Biotechnol 18: 1157-1161.
42. Sun B, Wu S, Li L, Li H, Zhang Q, et al. (2009) A metabolomic analysis of the toxicity of Aconitum sp. alkaloids in rats using gas chromatography/mass spectrometry. Rapid Commun Mass Spectrom 23: 1221-1228.
43. Kessler RC, Nelson CB, McGonagle KA, Liu J, Swartz M, et al. (1996) Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry Suppl: 17-30. (Pubitemid 26000488)
44. Hirschfeld RM (2001) The Comorbidity of Major Depression and Anxiety Disorders: Recognition and Management in Primary Care. Prim Care Companion J Clin Psychiatry 3: 244-254.
45. McCauley J, Kern DE, Kolodner K, Dill L, Schroeder AF, et al. (1997) Clinical characteristics of women with a history of childhood abuse: unhealed wounds. JAMA 277: 1362-1368. (Pubitemid 27194946)
46. Agid O, Shapira B, Zislin J, Ritsner M, Hanin B, et al. (1999) Environment and vulnerability to major psychiatric illness: a case control study of early parental loss in major depression, bipolar disorder and schizophrenia. Mol Psychiatry 4: 163-172. (Pubitemid 29163979)
47. Brindle JT, Antti H, Holmes E, Tranter G, Nicholson JK, et al. (2002) Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med 8: 1439-1444. (Pubitemid 36019430)
48. Wurtman RJ, Hefti F, Melamed E (1980) Precursor control of neurotransmitter synthesis. Pharmacol Rev 32: 315-335.
49. Wang L, Maher TJ, Wurtman RJ (2007) Oral L-glutamine increases GABA levels in striatal tissue and extracellular fluid. FASEB J 21: 1227-1232. (Pubitemid 46495711)
50. Mitani H, Shirayama Y, Yamada T, Maeda K, Ashby CR Jr, et al. (2006) Correlation between plasma levels of glutamate, alanine and serine with severity of depression. Prog Neuropsychopharmacol Biol Psychiatry 30: 1155-1158. (Pubitemid 43928219)
51. de Kivit S, Kraneveld AD, Garssen J, Willemsen LE (2011) Glycan recognition at the interface of the intestinal immune system: target for immune modulation via dietary components. Eur J Pharmacol 668 Suppl 1: S124-132.
52. Hirabayashi J, Hashidate T, Arata Y, Nishi N, Nakamura T, et al. (2002) Oligosaccharide specificity of galectins: a search by frontal affinity chromatography. Biochim Biophys Acta 1572: 232-254. (Pubitemid 35246347)
53. Shin T (2013) The pleiotropic effects of galectin-3 in neuroinflammation: a review. Acta Histochem 115: 407-411.
54. Starossom SC, Mascanfroni ID, Imitola J, Cao L, Raddassi K, et al. (2012) Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration. Immunity 37: 249-263.
55. Sakaguchi M, Okano H (2012) Neural stem cells, adult neurogenesis, and galectin-1: from bench to bedside. Dev Neurobiol 72: 1059-1067.
56. Kraneveld AD, de Theije CG, van Heesch F, Borre Y, de Kivit S, et al. (2014) The neuro-immune axis: prospect for novel treatments for mental disorders. Basic Clin Pharmacol Toxicol 114: 128-136.
57. McNamara RK, Jandacek R, Rider T, Tso P, Dwivedi Y, et al. (2010) Selective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorder. J Affect Disord 126: 303-311.
58. Das UN (2004) Perinatal supplementation of long-chain polyunsaturated fatty acids, immune response and adult diseases. Med Sci Monit 10: HY19-25.
59. Logue JA, Howell BR, Bell JG, Cossins AR (2000) Dietary n-3 long-chain polyunsaturated fatty acid deprivation, tissue lipid composition, ex vivo prostaglandin production, and stress tolerance in juvenile Dover sole (Solea solea L.). Lipids 35: 745-755. (Pubitemid 30624540)
60. Mathieu G, Oualian C, Denis I, Lavialle M, Gisquet-Verrier P, et al. (2011) Dietary n-3 polyunsaturated fatty acid deprivation together with early maternal separation increases anxiety and vulnerability to stress in adult rats. Prostaglandins Leukot Essent Fatty Acids 85: 129-136.
61. Jow GM, Yang TT, Chen CL (2006) Leptin and cholesterol levels are low in major depressive disorder, but high in schizophrenia. J Affect Disord 90: 21-27.
62. Olusi SO, Fido AA (1996) Serum lipid concentrations in patients with major depressive disorder. Biol Psychiatry 40: 1128-1131. (Pubitemid 26400877)
63. Kaufman D, Banerji MA, Shorman I, Smith EL, Coplan JD, et al. (2007) Early-life stress and the development of obesity and insulin resistance in juvenile bonnet macaques. Diabetes 56: 1382-1386. (Pubitemid 46715631)